文献速递生殖医学

重新评估IVF中的子宫内膜损伤:一个有前景的方法被过早放弃了吗?一篇批判性综述

Re-evaluating endometrial injury for IVF: was a promising approach abandoned prematurely? A critical review.
PubMed 文献 · Reprod Biomed Online · 2025-10-30

该综述汇总截至2025年1月31日20余年的研究,探讨方法学差异能否解释随机对照试验的矛盾结果。迄今最全面的个体参与者数据荟萃分析(13项RCT、4112例患者)显示,子宫内膜损伤后活产率有适度但统计学显著的改善(OR 1.29,95%CI 1.02-1.64),需治疗人数为26。多次活检方案、尤其RIF患者获益更明显,但证据存在显著异质性。

要点

  • 子宫内膜损伤后活产率适度改善:OR 1.29(95%CI 1.02-1.64),NNT为26。
  • 多次活检方案、尤其RIF患者获益更明显,优于未选择人群的单次活检。
  • 种植失败生物学异质性可能解释结果不一致,需生物标志物指导选择患者。

核心结论

  • 当前证据提示,对经过仔细选择的患者(尤其是RIF患者)采用多次活检方案,子宫内膜损伤可能带来适度改善。
  • 应就适度获益进行适当咨询,未来研究应从经验性应用转向生物标志物指导的患者选择。

研究设计与样本

  • 批判性综述,综合截至2025年1月31日20余年的研究。
  • 纳入迄今最全面的个体参与者数据荟萃分析,含13项随机对照试验、4112例患者。

主要发现

  • 子宫内膜损伤后活产率有适度但统计学显著的改善(OR 1.29,95%CI 1.02-1.64),需治疗人数为26。
  • 分析显示显著异质性:多次活检方案、尤其RIF患者,获益比未选择人群的单次活检方案更明显。
  • 种植失败的生物学异质性可能解释结局不一致,不同病因需要不同治疗策略。

关键数值与推荐

  • 活产率改善:OR 1.29(95%CI 1.02-1.64),对应对象为荟萃分析中13项RCT的4112例患者。
  • 需治疗人数(NNT)为26,对应同一荟萃分析人群。

临床怎么用

  • 对RIF等经过仔细选择的患者,可考虑多次活检的子宫内膜损伤方案,但需告知获益适度。
  • 不宜在未选择人群中常规单次活检应用,应结合患者病因个体化决策。

局限性

  • 随机对照试验结果存在冲突,研究间异质性显著。
  • 种植失败生物学异质性可能影响结果外推,需生物标志物指导的患者选择研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the early 2000s, endometrial injury has been proposed to enhance receptivity and improve pregnancy outcomes, particularly in individuals with recurrent implantation failure (RIF). However, randomized controlled trials have yielded conflicting results, creating ongoing debate about their clinical utility. This review synthesizes over 20 years of research through to 31 January 2025, examining whether methodological variations explain conflicting outcomes and assessing the clinical significance of reported benefits. The most comprehensive individual participant data meta-analysis to date, including 4112 patients from 13 randomized controlled trials, demonstrated a modest but statistically significant improvement in live birth rate following endometrial injury (OR 1.29, 95% CI 1.02-1.64), with a number needed to treat of 26. Analysis revealed significant heterogeneity: studies using multiple biopsies, particularly in RIF patients, showed more pronounced benefits than single-biopsy protocols in unselected populations. The biological heterogeneity of implantation failure probably explains inconsistent outcomes, as different aetiologies require distinct therapeutic approaches. Current evidence suggests that endometrial injury may provide modest improvements using multiple-biopsy protocols in carefully selected patients, particularly those with RIF, while highlighting the need for appropriate counselling regarding the modest benefits. Future research should transition from empirical application to biomarker-guided patient selection to identify which molecular subtypes benefit from specific interventions.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Shoham Z, Broekmans FJM, Casper RF, et al. Re-evaluating endometrial injury for IVF: was a promising approach abandoned prematurely? A critical review. Reprod Biomed Online. 2025. PMID: 42030757. doi:10.1016/j.rbmo.2025.105371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。